Advancing Science.
Transforming
Healthcare.
Dr. Guzmán bridges scientific research, clinical program development, product innovation, and strategic leadership to advance evidence-based healthcare and transform care delivery.
Where evidence meets
possibility.
More than two decades of scientific inquiry, clinical program development, healthcare product innovation, and executive experience inform Dr. Guzmán’s perspective on the future of healthcare.
Clinical & Translational Science
Evaluating evidence and translating research into meaningful clinical insight.
Rigor informs decisionsClinical Program Development
Designing evidence-based clinical programs, care pathways, and practical models of care.
Evidence guides programsHealthcare Product Innovation
Advancing healthcare products and technologies through scientific evaluation and strategy.
Science shapes innovationA career shaped by inquiry, innovation, and impact.
Dr. Guzmán’s professional experience spans clinical epidemiology, research and development, healthcare quality, scientific product evaluation, and pharmaceutical industry engagement. His perspective is shaped by what it takes to move from promising evidence to responsible decisions in practice.
Read the biographyGood science asks what is possible. Responsible innovation asks what the evidence can truly support.
Expertise across the health and life sciences.
Clinical Epidemiology
Research design, evidence interpretation, real-world evidence, and translational science.
Clinical Programs & Product Innovation
Evidence-based clinical program design, care pathways, scientific due diligence, and healthcare product evaluation.
Scientific Leadership
Clinical quality, governance, cross-disciplinary leadership, and healthcare strategy.
Pharmaceutical Advisory
Industry scientific exchange, therapeutic evidence, and key opinion leader perspectives.
Selected scientific contributions.
A focused selection of peer-reviewed research and publicly registered work reflects the evidence-oriented foundation of Dr. Guzmán’s career.
Effect of an intensive lifestyle intervention on the prevalence of metabolic syndrome and its components among overweight and obese adults
Journal of Public Health, 42(4):828–838. Peer-reviewed research examining changes in metabolic syndrome indicators.
Prospective Metabolic Indicator Study (PROMIS)
ClinicalTrials.gov NCT03588117. A prospective study concerning medical weight management and metabolic syndrome.
Ideas at the intersection
of research and reality.
Independent scientific perspectives on evidence, clinical program development, healthcare quality, and responsible innovation.
Clinical Evidence & Decision-Making
Rigorous appraisal of scientific findings and their practical implications.
Science-Driven Healthcare Innovation
Connecting clinical relevance, product evaluation, and effective implementation.
Quality & Accountability
Scientific governance and reliable approaches to care delivery.
Bring a scientific perspective to the conversation.
Scientific presentations, executive education, and select advisory conversations at the intersection of evidence and healthcare delivery.